4 reports

  • CLINICAL TRIALS - LEADING INDUSTRY SPONSORS
  • ALMOST 70% OF CKD-MBD CLINICAL TRIALS ARE CONDUCTED BY INDUSTRY SPONSORS IN SELECTED GEOGRAPHIES.

CKD-MBD Clinical Trials by Region: 2010-2018 CLINICAL TRIALS - THERAPY AREA PERSPECTIVE ALMOST ##% OF GENITOURINARY CLINICAL TRIALS ARE INVOLVED WITH CKD-MBD RESEARCH IN SELECTED GEOGRAPHIES.

  • Clinical Trial
  • Japan
  • United States
  • Market Competition
  • Mitsubishi Corporation

The clinical trial landscape is also examined, with an emphasis on trends in clinical trial failure rates, duration and size.

  • Clinical Trial
  • Dermatological Condition
  • Dermatology
  • Therapy
  • Mitsubishi Corporation
  • CANAGLIFLOZIN: ACTIVE / PLANNED CLINICAL TRIALS

KEY CLINICAL TRIAL RESULTS ##. ##. ##. ##.

  • Antidiabetics
  • Clinical Trial
  • Gliptins
  • Pharmaceutical
  • Mitsubishi Corporation
  • CLINICAL TRIALS BY SPONSOR TYPE
  • TOP COMPANIES PARTICIPATING IN MUCOCUTANEOUS LYMPH NODE SYNDROME (KAWASAKI DISEASE) THERAPEUTICS CLINICAL TRIALS

MUCOCUTANEOUS LYMPH NODE SYNDROME (KAWASAKI DISEASE) THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* CLINICAL TRIALS BY PHASE IN G## COUNTRIES MUCOCUTANEOUS LYMPH NODE SYNDROME (KAWASAKI DISEASE) THERAPEUTICS, G## COUNTRIES, CLINICAL

  • Clinical Trial
  • Dermatological Condition
  • Pathology
  • Therapy
  • Mitsubishi Corporation